QA: Cell Source Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001569340_2016_Cell_Source_Inc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'International Stem Cell CORP', 'shared_tokens': {'cell'}}]}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001569340, Cell Source Inc

  xvar xval
0 AssetsCurrent 338,212
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,267
3 remainder_Assets 28,282
4 LiabilitiesCurrent 6,049,586
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 76,424
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,097,580
9 ResearchAndDevelopmentExpense 392,925
10 remainder_Expenses 829,970
11 remainder_Revenues 0
12 remainder_NetIncome -183,630
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 367,761
1 Liabilities 6,126,010
2 Expenses 2,320,475
3 Revenues 0
4 StockholdersEquity -5,758,249
5 NetIncome -2,504,105
6 ComprehensiveNetIncome -2,504,105
7 BaseVar 4,498,938
8 EconomicCapitalRatiobeforeLimitedLiability -4.64
9 EconomicCapitalRatio 0.252

Edgar->Model Mapping

Feature Distribution